Tizanidine Hydrochloride
- Product NDC
- 60505-2649
- 11-digit product format
- 605052649
- Labeler code
- 60505
- Product ID
- 60505-2649_f68c762c-26fc-7c61-1a94-6b5110937eea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine Hydrochloride
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA078868
- Marketing category
- ANDA
- Marketing start
- 2012-02-06
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 485484, 485485, 485486 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-2649-0 | Tizanidine Hydrochloride | 10 in 1 CARTON | CAPSULE, GELATIN COATED | 10 | | 12 |
| 60505-2649-0 | Tizanidine Hydrochloride | 10 in 1 BLISTER PACK | CAPSULE, GELATIN COATED | 10 | | 12 |
| 60505-2649-3 | Tizanidine Hydrochloride | 30 in 1 BOTTLE | CAPSULE, GELATIN COATED | 30 | | 12 |
| 60505-2649-7 | Tizanidine Hydrochloride | 150 in 1 BOTTLE | CAPSULE, GELATIN COATED | 150 | | 12 |
| 60505-2649-8 | Tizanidine Hydrochloride | 1000 in 1 BOTTLE | CAPSULE, GELATIN COATED | 1000 | | 12 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| TIZANIDINE HYDROCHLORIDE | ACTIVE INGREDIENT | B53E3NMY5C | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| TIZANIDINE | ACTIVE MOIETY | 6AI06C00GW | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| POLYVINYL ACETATE PHTHALATE | INACTIVE INGREDIENT | 58QVG85GW3 | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 3 | |
| TIZANIDINE HYDROCHLORIDE | ACTIVE INGREDIENT | B53E3NMY5C | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| TIZANIDINE | ACTIVE MOIETY | 6AI06C00GW | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| POLYVINYL ACETATE PHTHALATE | INACTIVE INGREDIENT | 58QVG85GW3 | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE, GELATIN COATED [AVKARE, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-2649 | TIZANIDINE HYDROCHLORIDE CAPSULE, GELATIN COATED [APOTEX CORP.] | 11 | Current NDC, Legacy NDC, 5 package rows | 20241224_3dd09a0d-a782-1d6d-a552-b71e5bcbf2fe.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-2649-0 | 60505264900 | 10 in 1 CARTON | | | | | Historical |
| 60505-2649-3 | 60505264903 | 30 CAPSULE, GELATIN COATED in 1 BOTTLE (60505-2649-3) | 2012-02-06 | 0000-00-00 | No | No | Current |
| 60505-2649-7 | 60505264907 | 150 CAPSULE, GELATIN COATED in 1 BOTTLE (60505-2649-7) | 2012-02-06 | 0000-00-00 | No | No | Current |
| 60505-2649-8 | 60505264908 | 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (60505-2649-8) | 2012-02-06 | 0000-00-00 | No | No | Current |